Abstract: A hydrostatic cylinder with a gas pressure accumulator, which is preferably designed as a piston accumulator, and which is arranged concentrically on the outer circumference of the cylinder is disclosed. A gas pressure is produced via a constant pressure source and is limited or is essentially constant in the gas pressure accumulator and also a constant pressure medium pressure is independent of the degree of filling of the gas pressure accumulator.

Abstract: The present invention relates to novel monoclonal anti-human-GDF-15 antibodies, pharmaceutical compositions, kits, methods and uses and the cell lines capable of producing the monoclonal antibodies described herein. The present invention further relates to novel antibodies to human GDF-15 capable of inhibiting cancer growth.

Abstract: The present invention relates to novel monoclonal anti-human-GDF-15 antibodies, pharmaceutical compositions, kits, methods and uses and the cell lines capable of producing the monoclonal antibodies described herein. The present invention further relates to novel antibodies to human GDF-15 capable of inhibiting cancer growth.

Abstract: A hydraulic control block for controlling a supply of pressurizing medium to an electrohydraulic or servo hydraulic axle includes a plurality of internally situated hydraulic interfaces configured to fluidically connect at least one of a source of pressurizing medium and a pressurizing medium sink of the axle to any hydraulic cylinder selected from a group of hydraulic cylinders of different structural forms, wherein the internally situated hydraulic interfaces are configured to selectively supply pressurizing medium to the selected hydraulic cylinder. The control block further includes an insert part configured as a function of the structural form of the selected hydraulic cylinder such that each of the plurality of internally situated hydraulic interfaces is one of tapped and blocked for the purpose of the fluidic connection.

Abstract: The present invention relates to monoclonal anti-human-GDF-15 antibodies. The antibodies include chimeric antibodies and humanized antibodies. The invention also relates to monoclonal anti-human-GDF-15 antibodies including murine antibodies, chimeric antibodies and humanized antibodies for use in methods for the treatment of cancer cachexia and also for the treatment of cancer. The invention also provides pharmaceutical compositions, kits, methods and uses and cell lines capable of producing the monoclonal antibodies of the invention.

Abstract: The present invention relates to monoclonal anti-human-GDF-15 antibodies. The antibodies include chimeric antibodies and humanized antibodies. The invention also relates to monoclonal anti-human-GDF-15 antibodies including murine anti bodies, chimeric antibodies and humanized antibodies for use in methods for the treatment of cancer cachexia and also for the treatment of cancer. The invention also provides pharmaceutical compositions, kits, methods and uses and cell lines capable of producing the monoclonal antibodies of the invention.

Abstract: The present invention relates to monoclonal anti-human-GDF-15 antibodies. The antibodies include chimeric anti-bodies and humanized antibodies. The invention also relates to monoclonal anti-human-GDF-15 antibodies including murine anti-bodies, chimeric antibodies and humanized antibodies for use in methods for the treatment of cancer cachexia and also for the treatment of cancer. The invention also provides pharmaceutical compositions, kits, methods and uses and cell lines capable of producing the monoclonal antibodies of the invention.

Abstract: A method for producing a diaphragm for an ultrasonic sensor. In the method, a diaphragm body made of metal material is first provided. Next, an external surface region of the diaphragm body is degreased. The external surface region of the diaphragm body is then pickled. To pre-activate the subsequently applied second passivation layer, a first passivation layer is also deposited on the external surface region as a first layer.

Abstract: A hydrostatic cylinder with a gas pressure accumulator, which is preferably designed as a piston accumulator, and which is arranged concentrically on the outer circumference of the cylinder is disclosed. A gas pressure is produced via a constant pressure source and is limited or is essentially constant in the gas pressure accumulator and also a constant pressure medium pressure is independent of the degree of filling of the gas pressure accumulator.

Abstract: A hydraulic control block for controlling a supply of pressurizing medium to an electrohydraulic or servo hydraulic axle includes a plurality of internally situated hydraulic interfaces configured to fluidically connect at least one of a source of pressurizing medium and a pressurizing medium sink of the axle to any hydraulic cylinder selected from a group of hydraulic cylinders of different structural forms, wherein the internally situated hydraulic interfaces are configured to selectively supply pressurizing medium to the selected hydraulic cylinder. The control block further includes an insert part configured as a function of the structural form of the selected hydraulic cylinder such that each of the plurality of internally situated hydraulic interfaces is one of tapped and blocked for the purpose of the fluidic connection.

Abstract: An electrohydraulic system for use under water includes an electrohydraulic actuator and a container having an internal space provided for forming a volume which is enclosed from the environment and which is provided for receiving a hydraulic pressurized fluid. A hydraulic cylinder is provided in the internal space of the container, the inside of which is divided into a first cylinder chamber and a second cylinder chamber by a piston to which a first piston rod and a second piston rod are connected. The two active surfaces of the piston are the same or approximately the same size.

Abstract: The present invention relates to novel monoclonal anti-human-GDF-15 antibodies, pharmaceutical compositions, kits, methods and uses and the cell lines capable of producing the monoclonal antibodies described herein. The present invention further relates to novel antibodies to human GDF-15 capable of inhibiting cancer growth.

Abstract: The present invention relates to monoclonal anti-human-GDF-15 antibodies. The antibodies include chimeric antibodies and humanized antibodies. The invention also relates to monoclonal anti-human-GDF-15 antibodies including murine anti bodies, chimeric antibodies and humanized antibodies for use in methods for the treatment of cancer cachexia and also for the treatment of cancer. The invention also provides pharmaceutical compositions, kits, methods and uses and cell lines capable of producing the monoclonal antibodies of the invention.

Abstract: The present invention relates to monoclonal anti-human-GDF-15 antibodies. The antibodies include chimeric anti-bodies and humanized antibodies. The invention also relates to monoclonal anti-human-GDF-15 antibodies including murine anti-bodies, chimeric antibodies and humanized antibodies for use in methods for the treatment of cancer cachexia and also for the treatment of cancer. The invention also provides pharmaceutical compositions, kits, methods and uses and cell lines capable of producing the monoclonal antibodies of the invention.

Abstract: The present invention relates to novel monoclonal anti-human-GDF-15 antibodies, pharmaceutical compositions, kits, methods and uses and the cell lines capable of producing the monoclonal antibodies described herein. The present invention further relates to novel antibodies to human GDF-15 capable of inhibiting cancer growth.

Abstract: An electrohydraulic system for use under water includes an electrohydraulic actuator and a container having an internal space provided for forming a volume which is enclosed from the environment and which is provided for receiving a hydraulic pressurized fluid. A hydraulic cylinder is provided in the internal space of the container, the inside of which is divided into a first cylinder chamber and a second cylinder chamber by a piston to which a first piston rod and a second piston rod are connected. The two active surfaces of the piston are the same or approximately the same size.

Abstract: The present invention relates to monoclonal anti-human-GDF-15 antibodies. The antibodies include chimeric antibodies and humanized antibodies. The invention also relates to monoclonal anti-human-GDF-15 antibodies including murine antibodies, chimeric antibodies and humanized antibodies for use in methods for the treatment of cancer cachexia and also for the treatment of cancer. The invention also provides pharmaceutical compositions, kits, methods and uses and cell lines capable of producing the monoclonal antibodies of the invention.

Abstract: The present invention relates to novel monoclonal anti-human-GDF-15 antibodies, pharmaceutical compositions, kits, methods and uses and the cell lines capable of producing the monoclonal antibodies described herein. The present invention further relates to novel antibodies to human GDF-15 capable of inhibiting cancer growth.

Abstract: The present invention relates to monoclonal anti-human-GDF-15 antibodies. The antibodies include chimeric antibodies and humanized antibodies. The invention also relates to monoclonal anti-human-GDF-15 antibodies including murine antibodies, chimeric antibodies and humanized antibodies for use in methods for the treatment of cancer cachexia and also for the treatment of cancer. The invention also provides pharmaceutical compositions, kits, methods and uses and cell lines capable of producing the monoclonal antibodies of the invention.

Abstract: The present invention relates to monoclonal anti-human-GDF-15 antibodies. The antibodies include chimeric antibodies and humanized antibodies. The invention also relates to monoclonal anti-human-GDF-15 antibodies including murine antibodies, chimeric antibodies and humanized antibodies for use in methods for the treatment of cancer cachexia and also for the treatment of cancer. The invention also provides pharmaceutical compositions, kits, methods and uses and cell lines capable of producing the monoclonal antibodies of the invention.